Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that...

Related Keywords

United States ,Todd Harris ,Tyra Biosciences ,Nasdaq ,Exchange Commission ,Prnewswire Tyra Biosciences Inc ,Tyra Biosciences Inc ,Nextech Invest Ltd ,Linkedin ,Fibroblast Growth Factor Receptor ,Boxer Capital ,Securities Act ,Private Securities Litigation Reform Act ,